Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2020

Demographics in PANORAMA Patients

Nathan Steinle, MD

Show Description +

Nathan Steinle, MD, reviews data from the phase 3 PANORAMA study trials, which evaluated aflibercept (Eylea, Regeneron) for the treatment of nonproliferative diabetic retinopathy. Dr. Steinle analyzes the demographics of patients at the 52-week and 100-week timepoints to see if any baseline characteristics correlated with treatment outcomes.

Posted: 8/03/2020

Keywords:

aflibercept

•

Clinical Cases

•

Diabetic Retinopathy

•

retina-meeting-recap

Up Next

Sustained Release Fluocinolone Acetonide for Uveitis

Sustained Release Fluocinolone Acetonide for Uveitis

Dilraj Grewal, MD

MVP: A New Surgical Tool

MVP: A New Surgical Tool

Carl C. Awh, MD

PDR Treatment Patterns

PDR Treatment Patterns

Jeremiah Brown Jr, MD, MS

Next-Generation Intraoperative OCT

Next-Generation Intraoperative OCT

Lejla Vajzovic, MD

RGX-314: Phase 1/2a Data

RGX-314: Phase 1/2a Data

Arshad Khanani, MD

Intravitreal Methotrexate in the Prevention of Recurrent RD After PVR

Intravitreal Methotrexate in the Prevention of Recurrent RD After PVR

Scott Walter, MD

Using 3-Month Outcomes to Predict Long-Term Vision Outcomes in Wet AMD Patients

Using 3-Month Outcomes to Predict Long-Term Vision Outcomes in Wet AMD Patients

Paul Hahn, MD, PhD

AU-011 for Choroidal Melanoma

AU-011 for Choroidal Melanoma

Ivana Kim, MD

Mathematical Model for Outcomes in CEDAR and SEQUOIA

Mathematical Model for Outcomes in CEDAR and SEQUOIA

Peter Kaiser, MD

Back to All Videos

Demographics in PANORAMA Patients

Nathan Steinle, MD

Nathan Steinle, MD, reviews data from the phase 3 PANORAMA study trials, which evaluated aflibercept (Eylea, Regeneron) for the treatment of nonproliferative diabetic retinopathy. Dr. Steinle analyzes the demographics of patients at the 52-week and 100-week timepoints to see if any baseline characteristics correlated with treatment outcomes.

Posted: 8/03/2020

Keywords:

aflibercept

•

Clinical Cases

•

Diabetic Retinopathy

•

retina-meeting-recap

Please log in to leave a comment.

More From ASRS: 2020 Coverage

Sustained Release Fluocinolone Acetonide for Uveitis

Sustained Release Fluocinolone Acetonide for Uveitis

Dilraj Grewal, MD

MVP: A New Surgical Tool

MVP: A New Surgical Tool

Carl C. Awh, MD

PDR Treatment Patterns

PDR Treatment Patterns

Jeremiah Brown Jr, MD, MS

Next-Generation Intraoperative OCT

Next-Generation Intraoperative OCT

Lejla Vajzovic, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2020.